SUMMARY This paper reports on 9 patients aged 13-18 years (mean 15 4) with severe diabetic retinopathy. Two patients were prepubertal and 4 were going through puberty. Hypertension was present in 2 patients, while 4 had proteinuria. Severe preproliferative disease was present in 3 patients initially and proliferative retinopathy in the remainder. In 5 this retinopathy was considered to be florid. Two patients seen prior to 1975 had pituitary ablation, while those seen after 1975 were treated by extensive argon and xenon arc photocoagulation. Proliferative lesions regressed in both groups. At the latest follow-up 7 of the 9 patients achieved a final visual acuity of 6/9 or better in at least one eye. One patient became blind. Proliferative retinopathy advances rapidly in adolescents, but photocoagulation, as used now, can maintain vision in most.
Severe diabetic retinopathy is rarely reported under the age of 18 because duration of disease before puberty is not thought to be of significance in the development of microvascular disease. Immerslund' and Jackson et al.2 found no cases of proliferative retinopathy before the age of 18 in juveniles with as long as 17 years' duration of diabetes. Indeed, Jackson et al. 2 found that only 14% of their postpubertal insulin-dependent diabetics had any evidence of retinopathy. This is in contrast to the studies of Malone et al.,3 who found that 75% of their diabetic children had vascular abnormalities noted on fluorescein angiography, with 7% having early proliferative disease in at least one eye. Frank etal.,4 in a well controlled study, found no retinopathy in young diabetics with 0 to 4 years' duration of diabetes, 27% between 5 and 9 years', and 71% with over 10 years' duration. No proliferative retinopathy was noted in patients under age 18. The purpose of this report is to draw attention to the fact that, although rare, severe retinopathy can occur in adolescent diabetics, even before the onset of puberty, and to discuss possible treatment.
Patients
Tables 1-3. The age of the 9 adolescents ranged from 13 to 18 years (mean years), with a mean age at onset of diabetes of 5-7 years. The mean duration of diabetes was 9-7 years. Seven patients were female and 2 were male. They were followed up for a mean duration of 5-1 years (range 1-17 years). At presentation 6 had proliferative retinopathy, 5 with both new vessels on the disc (NVD) and new vessels elsewhere (NVE). Three Visual acuity on presentation was 6/12 or better in 13 of 18 eyes (72%). During follow-up, the visual acuity improved or remained stable in all eyes except those of patient 2. She became blind in both eyes due to thrombotic glaucoma. Seven of 9 patients achieved a final visual acuity of 6/9 or better in at least one eye (Fig. 1) .
The diabetic control at presentation was poor in 6 cases but improved in 8 during follow-up. In most cases this improvement occurred after switching from single daily injections of insulin to multiple injections or, more recently, to continuous subcutaneous insulin infusion (CSII). With regard to the patients' pubertal status (Tables 1A, 2A, 3A) at the time of presentation, 2 were prepubertal, 4 were entering puberty, and 3 were postpubertal. The systemic blood pressure was raised in 2 patients, and laboratory values of renal function were normal except for proteinuria in 4 patients (Tables 1B, 2B, 3B ). Other systemic illnesses included anorexia nervosa, hyperlipidaemia, and diabetic cardiomyopathy in one patient each. Of the 4 patients who had blood rheology tested 3 had abnormal blood viscosity and one showed abnormal red cell deformability.
TREATMENT
The 9 patients could be categorised into 3 groups according to the type of treatment given initially for the severe retinopathy. In group A (Table IA, B) no specific eye treatment was given because the retinopathy was at that time of severe background or preproliferative type and diabetic control was poor. In patient 3 the retinopathy improved with better control of the diabetes and hyperlipidaemia.
However, in patient 1 the retinopathy became more severe at least temporarily despite optimal control with CSII. In patient 2 the retinopathy initially improved with resolution of the anorexia nervosa retinopathy. In patient 5 argon laser therapy was first attempted, but the proliferative retinopathy became more aggressive in both eyes (Figs. 3A, B) . In both patients 4 and 5 the retinopathy regressed following pituitary ablation (Fig. 3C ). Both patients had residual areas of retinitis proliferans with mostly fibrous tissue. The vision in the left eye of patient 4 remained poor because of the pre-existing traction retinal detachment involving the macula. xenon bums (mean 565 bums). The retinopathy improved in all cases. In patients 7 and 9 the reduced visual acuity was initially due to macular oedema and ischaemia (Figs. 4B 4C) . In patient 7 the oedema resolved, but she remained with subsequent atrophy of the retinal pigment epithelium in both maculae. This accounted for the abnormal final visual acuity. Residual areas of inactive fibrovascular tissue (retinitis proliferans) were noted in patients 6, 7, and 9 ( Fig. 4D) . In patient 6 visual acuity remained at 6/9 in the left eye due to pre-existing preretinal traction over the macula (Fig. 5) .
The general health has been fair to good during the follow-up period in 7 of the 9 patients. The only death occurred in patient 9, due to rapidly progressive nephropathy and cardiomyopathy.
Discussion
The 9 cases reported in the present study are of a much younger age (mean 15'4 years) and with a shorter duration of diabetes (mean 9-7 years) than previous studies have indicated. Among juvenile diabetics the mean age of onset of PDR is said by Beetham5 and Deckert etal.6 to be 29-6 and 36-5 years respectively. This occurred after a mean duration of diabetes of 20 5 years.
The prevalence ofPDR among adolescent diabetics is low. Deckert et al.6 found that only 2% of their juvenile diabetics with PDR were under the age of20. In more recent studies78 PDR was seen in only 2 diabetics (age 18 or under) out of the 267 children and young adults examined. These figures are in agreement with the present series of 9 cases, which represent approximately 0-5% of the new retinopathy patients at the Hammersmith Hospital.
Many authors27-0 believe that good control is essential in preventing the development of severe retinopathy. In 6 of our 9 cases there was a longstanding history of poor diabetic control on 
